Acacia senegal Budmunchiamines as a Potential Adjuvant for Rejuvenating Phenicol Activities towards Escherichia coli-Resistant Strains

Int J Mol Sci. 2023 May 15;24(10):8790. doi: 10.3390/ijms24108790.

Abstract

The continuous emergence of bacterial resistance alters the activities of different antibiotic families and requires appropriate strategies to solve therapeutic impasses. Medicinal plants are an attractive source for researching alternative and original therapeutic molecules. In this study, the fractionation of natural extracts from A. senegal and the determination of antibacterial activities are associated with molecular networking and tandem mass spectrometry (MS/MS) data used to characterize active molecule(s). The activities of the combinations, which included various fractions plus an antibiotic, were investigated using the "chessboard" test. Bio-guided fractionation allowed the authors to obtain individually active or synergistic fractions with chloramphenicol activity. An LC-MS/MS analysis of the fraction of interest and molecular array reorganization showed that most identified compounds are Budmunchiamines (macrocyclic alkaloids). This study describes an interesting source of bioactive secondary metabolites structurally related to Budmunchiamines that are able to rejuvenate a significant chloramphenicol activity in strains that produce an AcrB efflux pump. They will pave the way for researching new active molecules for restoring the activity of antibiotics that are substrates of efflux pumps in enterobacterial-resistant strains.

Keywords: Acacia senegal; Budmunchiamines; Enterobacteriaceae; Escherichia coli; adjuvant; antibiotic resistance; efflux pumps; natural metabolites; phenicols.

MeSH terms

  • Acacia*
  • Anti-Bacterial Agents / chemistry
  • Chloramphenicol / metabolism
  • Chloramphenicol / pharmacology
  • Chromatography, Liquid
  • Escherichia coli / metabolism
  • Escherichia coli Proteins* / metabolism
  • Humans
  • Microbial Sensitivity Tests
  • Multidrug Resistance-Associated Proteins / metabolism
  • Senegal
  • Tandem Mass Spectrometry

Substances

  • Anti-Bacterial Agents
  • Chloramphenicol
  • AcrB protein, E coli
  • Multidrug Resistance-Associated Proteins
  • Escherichia coli Proteins

Grants and funding

This research was funded by AMU University, INSERM, Campus France and the French Embassy; The APC was funded by AMU University and INSERM.